EU AI Act Classification: Understanding High-Risk AI Systems in Healthcare
Healthcare organizations must navigate the EU AI Act's tiered classification system as enforcement approaches. Here's what qualifies as high-risk.
Understanding AI Classification Under the EU AI Act
As the [EU AI Act](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32024R1689) moves toward full enforcement, healthcare organizations must understand how their AI systems will be classified and what obligations follow.
High-Risk Categories in Healthcare
The regulation specifically identifies healthcare AI as a high-risk category when systems are intended for:
- Diagnostic assistance: AI that aids in detecting diseases or conditions
- Treatment recommendations: Systems suggesting therapeutic interventions
- Risk assessment: Tools predicting patient outcomes or disease progression
- Medical device integration: AI embedded in regulated medical devices under the [EU Medical Device Regulation (MDR)](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)
Compliance Requirements for High-Risk Systems
Organizations deploying high-risk AI must implement:
- Risk management systems: Continuous identification and mitigation of AI-related risks (Article 9)
- Data governance: Ensuring training data quality and representativeness (Article 10)
- Technical documentation: Comprehensive records of system design and testing (Article 11)
- Human oversight: Mechanisms for human intervention in AI decisions (Article 14)
Timeline Considerations
Key enforcement dates organizations should note per the [official implementation timeline](https://digital-strategy.ec.europa.eu/en/policies/regulatory-framework-ai):
- Prohibited AI practices: Already enforceable (February 2025)
- High-risk system requirements: Phased implementation through August 2026
- General-purpose AI obligations: Following product-specific timelines
Practical Steps
Healthcare entities should conduct an inventory of AI systems, classify each according to the risk framework, and develop compliance roadmaps prioritizing high-risk deployments.
The intersection of AI regulation and existing medical device frameworks creates additional complexity that requires careful navigation with legal and regulatory expertise.